JP2015510935A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510935A5
JP2015510935A5 JP2015501777A JP2015501777A JP2015510935A5 JP 2015510935 A5 JP2015510935 A5 JP 2015510935A5 JP 2015501777 A JP2015501777 A JP 2015501777A JP 2015501777 A JP2015501777 A JP 2015501777A JP 2015510935 A5 JP2015510935 A5 JP 2015510935A5
Authority
JP
Japan
Prior art keywords
composition
dtpa
particles
average diameter
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015501777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510935A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031336 external-priority patent/WO2013142258A1/en
Publication of JP2015510935A publication Critical patent/JP2015510935A/ja
Publication of JP2015510935A5 publication Critical patent/JP2015510935A5/ja
Ceased legal-status Critical Current

Links

JP2015501777A 2012-03-22 2013-03-14 封入ジエチレントリアミンペンタアセテート粒子の経口送達のための組成物および方法 Ceased JP2015510935A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261614333P 2012-03-22 2012-03-22
US61/614,333 2012-03-22
US201361771873P 2013-03-03 2013-03-03
US61/771,873 2013-03-03
PCT/US2013/031336 WO2013142258A1 (en) 2012-03-22 2013-03-14 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles

Publications (2)

Publication Number Publication Date
JP2015510935A JP2015510935A (ja) 2015-04-13
JP2015510935A5 true JP2015510935A5 (OSRAM) 2016-05-12

Family

ID=48014341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501777A Ceased JP2015510935A (ja) 2012-03-22 2013-03-14 封入ジエチレントリアミンペンタアセテート粒子の経口送達のための組成物および方法

Country Status (8)

Country Link
US (1) US9040091B2 (OSRAM)
EP (1) EP2827853A1 (OSRAM)
JP (1) JP2015510935A (OSRAM)
KR (1) KR20140139563A (OSRAM)
AU (1) AU2013235491A1 (OSRAM)
CA (1) CA2867701C (OSRAM)
MX (1) MX2014011123A (OSRAM)
WO (1) WO2013142258A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2939760C (en) * 2014-02-18 2022-05-31 Medesis Pharma Use of a reverse-micellar system for delivering chelators of radionuclides and metals
EP3364967A2 (en) 2015-10-23 2018-08-29 Vifor (International) AG Ferroportin inhibitors
JP2018052884A (ja) * 2016-09-29 2018-04-05 菊川 正 放射線核種キレート化剤を内包する経口投与剤
JOP20180036A1 (ar) 2017-04-18 2019-01-30 Vifor Int Ag أملاح لمثبطات فروبورتين جديدة
TW202102478A (zh) 2019-04-01 2021-01-16 瑞士商威佛(國際)股份有限公司 新穎的鐵螯合物
WO2024253935A1 (en) 2023-06-05 2024-12-12 Nanopharmaceutics, Inc. Compositions and methods for oral delivery of sustained release crystalline prx-3140

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU660852B2 (en) 1992-11-25 1995-07-06 Elan Pharma International Limited Method of grinding pharmaceutical substances
TW384224B (en) 1994-05-25 2000-03-11 Nano Sys Llc Method of preparing submicron particles of a therapeutic or diagnostic agent
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
UA76810C2 (uk) * 2001-12-10 2006-09-15 Мерк Енд Ко., Інк. Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
US7910086B1 (en) * 2005-01-04 2011-03-22 Gp Medical, Inc. Nanoparticles for protein drug delivery
JP2009500163A (ja) 2005-07-07 2009-01-08 ナノセラピューティクス・インコーポレイテッド 粉末を製粉および調製する方法及びそれにより得られる組成物
CA2637215C (en) * 2006-02-17 2011-06-07 Sri International Oral dtpa for radionuclide chelation
AU2011243226A1 (en) * 2010-04-21 2012-10-11 Nanomega Medical Corporation A pharmaceutical composition of nanoparticles

Similar Documents

Publication Publication Date Title
JP2015510935A5 (OSRAM)
MX2012004472A (es) Forma farmaceutica oral solida contra el uso indebido y que tiene un perfil especifico de liberacion modificada.
TWI539969B (zh) Composition for oral use
JP2016065086A5 (OSRAM)
NZ626401A (en) A novel formulation of naproxen
JP2011046962A5 (OSRAM)
JP2009512663A5 (OSRAM)
ZA201708286B (en) Orodispersible dosage unit containing an estetrol component
NZ722952A (en) Inhalable pharmaceutical compositions
JP2016060682A5 (OSRAM)
JP2011506330A5 (OSRAM)
PH12013501846A1 (en) A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
RU2012150444A (ru) Продукт для ухода за полостью рта и способы его применения и производства
RU2015110824A (ru) Фармацевтическая или нутрицевтическая композиция с замедленным высвобождением и стойкостью к воздействию этанола
JP2012158592A5 (OSRAM)
JP2012012392A5 (OSRAM)
EA200900250A1 (ru) Частица в форме инкапсулированной капельки и способ приготовления такой частицы
RU2015128794A (ru) Композиция перорально распадающейся таблетки, обеспечивающая повышенную биодоступность
HRP20251373T1 (hr) Mikroporozni cirkonijev silikat za liječenje hiperkalijemije
MX2013007237A (es) Peliculas y composiciones que comprenden las mismas.
JP2014218522A5 (OSRAM)
JP2014514391A5 (OSRAM)
RU2012136858A (ru) Средство для полости рта по уходу за чувствительной эмалью
JP2011503190A5 (OSRAM)
RU2017118329A (ru) Частицы кадотрила